Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-03-04 Conway Vikki L See "Remarks" Option exercise 10b5-1 +7,117 13,734
2024-03-04 Conway Vikki L See "Remarks" Sale 10b5-1 −2,042 $13.37 $27K 11,692
2024-03-04 Conway Vikki L See "Remarks" Option exercise · Restricted Share Units 10b5-1 −7,117 14,237
2024-03-04 Conway Vikki L See "Remarks" Grant or award · Restricted Share Units 10b5-1 +33,482 33,482
2024-03-04 Fox Christine EVP, Head of U.S. Commercial Grant or award · Restricted Share Units +81,845 81,845
2024-03-04 Grant Angus EVP, Business Development Grant or award · Restricted Share Units +52,083 52,083
2024-03-04 Francis Richard D President and CEO Sale 10b5-1 −31,061 $13.34 $414K 123,295
2024-03-04 Francis Richard D President and CEO Grant or award · Restricted Share Units 10b5-1 +200,892 200,892
2024-03-04 Drape Eric Executive VP Global Operations Option exercise 10b5-1 +33,512 77,928
2024-03-04 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units 10b5-1 −33,512 67,024
2024-03-04 Daniell Richard Exec. VP, European Commercial Sale 10b5-1 −62,250 $13.34 $830K 69,770
2024-03-04 Daniell Richard Exec. VP, European Commercial Option exercise 10b5-1 +33,512 103,282
2024-03-04 Daniell Richard Exec. VP, European Commercial Sale 10b5-1 −33,512 $13.34 $447K 69,770
2024-03-04 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units 10b5-1 −33,512 67,024
2024-03-04 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units 10b5-1 +81,845 81,845
2024-03-04 Hughes Eric A See "Remarks" Sale 10b5-1 −8,045 $13.34 $107K 16,855
2024-03-04 Hughes Eric A See "Remarks" Grant or award · Restricted Share Units 10b5-1 +93,005 93,005
2024-03-04 Sabag Mark EVP, International Markets Option exercise +33,512 400,693
2024-03-04 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −33,512 67,024
2024-03-04 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +74,404 74,404

Page 23 of 76 · 1,517 trades